Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.25
+0.03002.46%
Post-market: 1.19-0.0600-4.80%17:44 EDT
Volume:104.60K
Turnover:128.14K
Market Cap:62.27M
PE:-1.12
High:1.33
Open:1.21
Low:1.19
Close:1.22
Loading ...
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
Jun 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Mar 20, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 07, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2023

Major Issues Report

8-K - Current report